Formulation and evaluation of water-in-oil amoxicillin-loaded nanoemulsions using for Helicobacter pylori eradication

Process Biochemistry

Volumn 47, Issue 10, 2012, Pages 1469-1478

  Lin, Yu Hsin ^a   Chiou, Shu Fen ^b   Lai, Chih Ho ^c   Tsai, Shih Chang ^a   Chou, Chih Wei ^a   Peng, Shu Fen ^a   He, Zih Sian ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Amoxicillin; Emulsification system; Helicobacter pylori; Nanoemulsion particle

Indexed keywords

AMOXICILLIN; BASOLATERAL MEMBRANES; DRUG CONCENTRATION; HELICOBACTER PYLORI; IN-VITRO ANALYSIS; IN-VIVO; LOW CONCENTRATIONS; MOUSE MODELS; NANO-EMULSIONS; NANOCARRIERS; NANOEMULSION; POSITIVELY CHARGED; RESIDENCE TIME; WATER-IN-OIL;

ENZYME INHIBITION;

EMULSIFICATION;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 84863796085     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2012.05.019     Document Type: Article

References (45)

1. D.A. Vattem, Y.T. Lin, R. Ghaedian, and K. Shetty Cranberry synergies for dietary management of Helicobacter pylori infections Process Biochem 46 2005 1583 1592
2. W.L. Peterson Helicobacter pylori and peptic ulcer disease N Engl J Med 324 1991 1043 1048
3. R. Hejazi, and M. Amiji Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracyline-loaded chitosan microspheres Int J Pharm 235 2002 87 94
4. R.W. van der Hulst, J.J. Keller, E.A. Rauws, and G.N. Tytgat Treatment of Helicobacter pylori infection: a review of the world literature Helicobacter 1 1996 6 19
5. K. van Amsterdam, A.H. van Vliet, J.G. Kusters, and A. van der Ende Of microbe and man: determinants of Helicobacter pylori-related diseases FEMS Microbiol Rev 30 2006 131 156
6. T.L. Cover, and M.J. Blaser Purification and characterization of the vacuolating toxin from Helicobacter pylori J Biol Chem 267 1992 10570 10575
7. K. Khanvilkar, M.D. Donovan, and D.R. Flanagan Drug transfer through mucus Adv Drug Deliv Rev 48 2001 173 193
8. C. Gonçalves, P. Pereira, and M. Gama Self-assembled hydrogel nanoparticles for drug delivery applications Materials 3 2010 1420 1460
9. H. Hillaireau, T. Le Doan, M. Appel, and P. Couvreur Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages J Control Release 116 2006 346 352
10. H. Hillaireau, T. Le Doan, M. Besnard, H. Chacun, J. Janin, and P. Couvreur Encapsulation of antiviral nucleotide analogues azidothymidine- triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules Int J Pharm 324 2006 37 42
11. S. Motohiro, K. Yohei, K. Yukitaka, A. Shuji, and M. Ryuichi Effect of the hydrophilic surfactants on the preparation and encapsulation efficiency in course and fine W/O/W type emulsions Colloids Surf A Physicochem Eng Asp 238 2004 83 90
12. X. Jina, T.A. Ugine, J. Chena, and A.D. Streetta Method for determining the best hydrophilic-lipophilic balance (HLB) number for a compatible non-ionic surfactant in formulation development for aerial conidia of metarhizium anisopliae (Hypocreales: Clavicipitaceae) Biocontrol Sci Technol 19 2009 341 347
13. J. Boyd, C. Parkinson, and P. Sherman Factors affecting emulsion stability and the HLB concept J Colloid Interface Sci 41 1972 359 370
14. Z.S. Bayindir, and N. Yuksel Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery J Pharm Sci 99 2010 2049 2060
15. S. Sajjadi, M. Zerfa, and B.W. Brooks Phase inversion in p-xylene/water emulsions with the non-ionic surfactant pair sorbitan monolaurate/ polyoxyethylene sorbitan monolaurate (Span 20/Tween 20) Colloids Surf A Physicochem Eng Asp 218 2003 241 254
16. S. Shah, R. Qaqish, V. Patel, and M. Amiji Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection J Pharm Pharmacol 51 1999 667 672
17. J.M. Kim, J.S. Kim, H.C. Jung, N. Kim, Y.J. Kim, and I.S. Song Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea Antimicrob Agents Chemother 48 2004 4843 4847
18. H. Endo, H. Yoshida, N. Ohmi, K. Ohta, and S. Higuchi Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin J Antimicrob Chemother 48 2001 923 926
19. H. Endo, H. Yoshida, N. Ohmi, K. Ohta, S. Higuchi, and T. Suga Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin J Antimicrob Chemother 50 2002 285 288
20. A.J. Hall, M. Tripp, T. Howell, G. Darland, J.S. Bland, and J.G. Babish Gastric mucosal cell model for estimating relative gastrointestinal toxicity of non-steroidal anti-inflammatory drugs Prostaglandins Leukot Essent Fatty Acids 75 2006 9 17
21. Y. Li, W.P. Wang, H.Y. Wang, and C.H. Cho Intragastric administration of heparin enhances gastric ulcer healing through a nitric oxide-dependent mechanism in rats Eur J Pharmacol 399 2000 205 214
22. X.Z. Shu, K.J. Zhu, and W. Song Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release Int J Pharm 212 2001 19 28
23. H. Sheng, P.K. Shah, and K.L. Audus Sucralfate effects on mucus synthesis and secretion by human gastric epithelium in vitro Int J Pharm 131 1996 159 169
24. Y.H. Lin, C.H. Chang, Y.S. Wu, Y.M. Hsu, S.F. Chiu, and Y.J. Chen Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy Biomaterials 30 2009 3332 3342
25. C.H. Chang, W.Y. Huang, C.H. Lai, Y.M. Hsu, Y.H. Yao, and T.Y. Chen Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori Acta Biomater 7 2011 593 603
26. J.S. Kim, J.M. Kim, H.C. Jung, and I.S. Song Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway Dig Dis Sci 46 2001 2277 2284
27. E.E. Hennig, M.M. Godlewski, E. Butruk, and J. Ostrowski Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters HeLa cell adhesion and cytoskeletal organization in vitro FEMS Immunol Med Microbiol 44 2005 143 150
28. D. Sieveking, S.T. Leach, H.M. Mitchell, and A.S. Day Role of serum factors in epithelial cell responses to Helicobacter pylori infection in vitro J Gastroenterol Hepatol 20 2005 1610 1615
29. Z. Ma, T.M. Lim, and L.Y. Lim Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats Int J Pharm 293 2005 271 280
30. W. Liu, S. Sun, Z. Cao, X. Zhang, K. Yao, and W.W. Lu An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes Biomaterials 26 2005 2705 2711
31. T.S. Leong, T.J. Wooster, S.E. Kentish, and M. Ashokkumar Minimising oil droplet size using ultrasonic emulsification Ultrason Sonochem 16 2009 721 727
32. H.A. Tsai, D.H. Huang, R.C. Ruaan, and J.Y. Lai Mechanical properties of asymmetric polysulfone membranes containing surfactant as additives Ind Eng Chem Res 40 2001 5917 5922
33. N.S. Barakat, and A.E. Yassin In vitro characterization of carbamazepine-loaded precifac lipospheres Drug Deliv 13 2006 95 104
34. H. Kunieda, and K. Shinoda Evaluation of the hydrophile-lipophile balance (HLB) of nonionic surfactants. I. Multisurfactant systems J Colloid Interface Sci 107 1985 107 121
35. P. Izquierdo, J. Esquena, ThF. Tadros, C. Dederen, M.J. Garcia, and N. Azemar Formation and stability of nano-emulsions prepared using the phase inversion temperature method Langmuir 18 2002 26 30
36. D.R. Scott, D. Weeks, C. Hong, S. Postius, K. Melchers, and G. Sachs The role of internal urease in acid resistance of Helicobacter pylori Gastroenterology 114 1998 58 70
37. W. Beil, and P. Kilian EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells Phytomedicine 14 2007 5 8
38. P.L. Bardonnet, V. Faivre, W.J. Pugh, J.C. Piffaretti, and F. Falson Gastroretentive dosage forms: overview and special case of Helicobacter pylori J Control Release 111 2006 1 18
39. V. Pelicic, J.M. Reyrat, L. Sartori, C. Pagliaccia, R. Rappuoli, and J.L. Telford Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity Microbiology 145 1999 2043 2050
40. J.K. Patel, and M.M. Patel Stomach specific anti-Helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres Curr Drug Deliv 4 2007 41 50
41. C.H. Lai, C.H. Kuo, P.Y. Chen, S.K. Poon, C.S. Chang, and W.C. Wang Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates J Antimicrob Chemother 57 2006 466 471
42. M.P. Cooreman, P. Krausgrill, and K.J. Hengels Local gastric and serum amoxicillin concentrations after different oral application forms Antimicrob Agents Chemother 37 1993 1506 1509
43. J.C. Atherton, A. Cockayne, M. Balsitis, G.E. Kirk, C.J. Hawkey, and R.C. Spiller Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxicillin and cimetidine Gut 36 1995 670 674
44. M. Thanou, J.C. Verhoef, and H.E. Junginger Chitosan and its derivatives as intestinal absorption enhancers Adv Drug Deliv Rev 50 2001 S91 S101
45. J.A. Ko, H.J. Lim, and H.J. Park Effect of microencapsulated precipitants of Lactobacillus casei ATCC 393 on Helicobacter pylori eradication Process Biochem 46 2011 631 635